68 Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review
Journal of Nuclear Medicine Technology · 2023
DOI: 10.2967/jnmt.122.264694 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine Technology, 2023. Verfasst von Rahaf AlSadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science, Texas A&M University at Qatar, Doha, Qatar. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Neuroblastoma, Organometallic Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science, Texas A&M University at Qatar, Doha, Qatar.
- Department of Pediatrics, Division of Hematology-Oncology, Sidra Medicine, Doha, Qatar.
- Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar; and.
- QMC, Troy, Michigan mehdjeki@gmail.com.
Zitieren
APA
AlSadi, R., Maaz, A. U. R., Bouhali, O., & Djekidel, M. (2023). 68 Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review. Journal of Nuclear Medicine Technology. https://doi.org/10.2967/jnmt.122.264694
Vancouver
AlSadi R, Maaz AUR, Bouhali O, Djekidel M. 68 Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review. Journal of Nuclear Medicine Technology. 2023. doi:10.2967/jnmt.122.264694
BibTeX
@article{AlSadi2023,
author = {AlSadi, Rahaf and Maaz, Ata Ur Rehman and Bouhali, Othmane and Djekidel, Mehdi},
title = {68 Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review},
journal = {Journal of Nuclear Medicine Technology},
year = {2023},
doi = {10.2967/jnmt.122.264694}
}
EUVIMED